{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T02:44:54Z","timestamp":1792118694027,"version":"4.4.0"},"reference-count":81,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Intern Med"],"published-print":{"date-parts":[[2026,7,1]]},"abstract":"<jats:sec id=\"ab-irv260002-1\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Anxiety disorders and symptoms are prevalent and burdensome, and patients are most likely to seek treatment in primary care settings. However, anxiety is underdetected and undertreated. This narrative review details behavioral and pharmacological treatment options that are feasible and effective in primary care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-irv260002-2\">\n                    <jats:title>Observations<\/jats:title>\n                    <jats:p>Screening for anxiety is recommended for primary care patients younger than 65 years. Given that anxiety often involves somatic symptoms, assessment should include patient-reported symptom measures, clinical interview, physical examination, and appropriate laboratory tests. For subthreshold symptoms (those that do not meet diagnostic criteria for anxiety disorders) and adjustment-related anxiety, starting with self-help and behavioral treatment is recommended. When deciding between behavioral, pharmacological, or combined treatment for anxiety disorders, consider the presentation, patient preferences, potential adverse effects, and treatment history, and engage in shared decision-making. Cognitive-behavioral therapy (CBT) is the first-line behavioral treatment for anxiety. Brief CBT in primary care delivered by embedded behavioral health clinicians is effective. First-line pharmacotherapy for anxiety disorders includes several selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors, which tend to be well tolerated without considerable long-term adverse effects. The main decision for pharmacological treatment is between a daily medication and a short-acting medication taken as needed for intermittent symptoms or while awaiting the effect of a daily medication. Benzodiazepines are not recommended due to risk of adverse effects, especially with long-term use. The Collaborative Care Management model, which involves collaboration between primary care clinicians, consulting psychiatrists, and care managers who monitor patient progress and provide behavioral treatment, improves anxiety outcomes compared to usual primary care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-irv260002-3\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>Clinicians should recognize common anxiety presentations and understand how to differentiate between anxiety and other psychiatric or medical conditions. Referring patients to behavioral health specialists for CBT and\/or prescribing recommended pharmacotherapy with Collaborative Care Management can help to reduce patient morbidity and improve functioning.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamainternmed.2026.0395","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T15:00:44Z","timestamp":1777906844000},"page":"878","source":"Crossref","is-referenced-by-count":4,"title":["Treatment of Anxiety for Adults in Primary Care Settings"],"prefix":"10.1001","volume":"186","author":[{"given":"Robyn L.","family":"Shepardson","sequence":"first","affiliation":[{"name":"VA Center for Integrated Healthcare, Syracuse VA Medical Center, Syracuse, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S.","family":"Khan","sequence":"additional","affiliation":[{"name":"Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine A.","family":"Buckheit","sequence":"additional","affiliation":[{"name":"VA Center for Integrated Healthcare, Syracuse VA Medical Center, Syracuse, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer S.","family":"Funderburk","sequence":"additional","affiliation":[{"name":"VA Center for Integrated Healthcare, Syracuse VA Medical Center, Syracuse, New York"},{"name":"Department of Psychiatry, University of Rochester, Rochester, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"6","key":"irv260002r1","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1001\/archpsyc.62.6.593","article-title":"Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.","volume":"62","author":"Kessler","year":"2005","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"irv260002r2","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1080\/13651501.2021.1941120","article-title":"Subsyndromal generalised anxiety disorder: operationalisation and epidemiology\u2014a systematic literature survey.","volume":"26","author":"Volz","year":"2022","journal-title":"Int J Psychiatry Clin Pract"},{"issue":"10","key":"irv260002r3","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1001\/archpsyc.1996.01830100026004","article-title":"Subthreshold psychiatric symptoms in a primary care group practice.","volume":"53","author":"Olfson","year":"1996","journal-title":"Arch Gen Psychiatry"},{"issue":"12","key":"irv260002r4","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1017\/S0033291710000176","article-title":"Functioning and disability levels in primary care out-patients with one or more anxiety disorders.","volume":"40","author":"Sherbourne","year":"2010","journal-title":"Psychol Med"},{"issue":"5","key":"irv260002r5","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.cpr.2007.01.015","article-title":"Quality of life in the anxiety disorders: a meta-analytic review.","volume":"27","author":"Olatunji","year":"2007","journal-title":"Clin Psychol Rev"},{"key":"irv260002r6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpr.2020.101894","article-title":"Anxiety disorders and healthcare utilization: A systematic review.","volume":"81","author":"Horenstein","year":"2020","journal-title":"Clin Psychol Rev"},{"key":"irv260002r7","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.cpr.2015.11.008","article-title":"Anxiety and its disorders as risk factors for suicidal thoughts and behaviors: a meta-analytic review.","volume":"43","author":"Bentley","year":"2016","journal-title":"Clin Psychol Rev"},{"key":"irv260002r8","doi-asserted-by":"publisher","DOI":"10.1177\/21501327211023871","article-title":"Assessing primary care contributions to behavioral health: a cross-sectional study using medical expenditure panel survey.","volume":"12","author":"Jetty","year":"2021","journal-title":"J Prim Care Community Health"},{"issue":"7","key":"irv260002r9","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/da.22360","article-title":"Detection of anxiety disorders in primary care: a meta-analysis of assisted and unassisted diagnoses.","volume":"32","author":"Olariu","year":"2015","journal-title":"Depress Anxiety"},{"issue":"2","key":"irv260002r10","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1176\/appi.focus.20160044","article-title":"Anxiety disorders and general medical conditions: current research and future directions.","volume":"15","author":"Aquin","year":"2017","journal-title":"Focus (Am Psychiatr Publ)"},{"key":"irv260002r11","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.873126","article-title":"Anxiety in the medically ill: a systematic review of the literature.","volume":"13","author":"Romanazzo","year":"2022","journal-title":"Front Psychiatry"},{"issue":"1","key":"irv260002r12","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12875-019-0996-6","article-title":"Prioritising physical and psychological symptoms: what are the barriers and facilitators to the discussion of anxiety in the primary care consultation?","volume":"20","author":"Barnes","year":"2019","journal-title":"BMC Fam Pract"},{"issue":"7","key":"irv260002r13","doi-asserted-by":"publisher","first-page":"970","DOI":"10.4088\/JCP.09m05626blu","article-title":"Quality of and patient satisfaction with primary health care for anxiety disorders.","volume":"72","author":"Stein","year":"2011","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"irv260002r14","first-page":"157","article-title":"Generalized anxiety disorder and panic disorder in adults.","volume":"106","author":"DeGeorge","year":"2022","journal-title":"Am Fam Physician"},{"issue":"24","key":"irv260002r15","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1001\/jama.2022.22744","article-title":"Anxiety disorders: a review.","volume":"328","author":"Szuhany","year":"2022","journal-title":"JAMA"},{"issue":"24","key":"irv260002r16","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1001\/jama.2023.9301","article-title":"Screening for anxiety disorders in adults: US Preventive Services Task Force recommendation statement.","volume":"329","author":"Barry","year":"2023","journal-title":"JAMA"},{"issue":"3","key":"irv260002r17","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/mpr.1359","article-title":"Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States.","volume":"21","author":"Kessler","year":"2012","journal-title":"Int J Methods Psychiatr Res"},{"issue":"4","key":"irv260002r18","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.psc.2024.04.015","article-title":"Anxiety disorders in later life.","volume":"47","author":"Johnco","year":"2024","journal-title":"Psychiatr Clin North Am"},{"key":"irv260002r19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2015.05.031","article-title":"Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990-2014: a systematic review and meta-analysis.","volume":"154","author":"Lai","year":"2015","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"irv260002r20","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s00127-007-0299-4","article-title":"Social anxiety disorder above and below the diagnostic threshold: prevalence, comorbidity and impairment in the general population.","volume":"43","author":"Fehm","year":"2008","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"issue":"3","key":"irv260002r21","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1192\/bjp.bp.110.080572","article-title":"Psychiatric history and subthreshold symptoms as predictors of the occurrence of depressive or anxiety disorder within 2 years.","volume":"198","author":"Karsten","year":"2011","journal-title":"Br J Psychiatry"},{"issue":"3","key":"irv260002r23","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD015455","article-title":"Generalized Anxiety Disorder 7-item (GAD-7) and 2-item (GAD-2) scales for detecting anxiety disorders in adults.","volume":"3","author":"Akt\u00fcrk","year":"2025","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"irv260002r24","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7.","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch Intern Med"},{"issue":"5","key":"irv260002r25","doi-asserted-by":"publisher","first-page":"317","DOI":"10.7326\/0003-4819-146-5-200703060-00004","article-title":"Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection.","volume":"146","author":"Kroenke","year":"2007","journal-title":"Ann Intern Med"},{"issue":"1","key":"irv260002r26","doi-asserted-by":"publisher","first-page":"7","DOI":"10.5498\/wjp.v9.i1.7","article-title":"Comorbidity of bipolar and anxiety disorders: an overview of trends in research.","volume":"9","author":"Spoorthy","year":"2019","journal-title":"World J Psychiatry"},{"issue":"2","key":"irv260002r27","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.genhosppsych.2013.10.013","article-title":"Diagnostic specificity and mental health service utilization among veterans with newly diagnosed anxiety disorders.","volume":"36","author":"Barrera","year":"2014","journal-title":"Gen Hosp Psychiatry"},{"issue":"707","key":"irv260002r28","doi-asserted-by":"publisher","first-page":"e450","DOI":"10.3399\/BJGP.2020.0959","article-title":"GPs\u2019 and patients\u2019 views on the value of diagnosing anxiety disorders in primary care: a qualitative interview study.","volume":"71","author":"Archer","year":"2021","journal-title":"Br J Gen Pract"},{"key":"irv260002r29","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1530\/EDM-17-0176","article-title":"Unusual presentation of pheochromocytoma: thirteen years of anxiety requiring psychiatric treatment.","volume":"2018","author":"Alguire","year":"2018","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"6","key":"irv260002r32","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.cpr.2014.06.002","article-title":"Client preferences affect treatment satisfaction, completion, and clinical outcome: a meta-analysis.","volume":"34","author":"Lindhiem","year":"2014","journal-title":"Clin Psychol Rev"},{"issue":"4","key":"irv260002r33","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1093\/fampra\/cmaa002","article-title":"Barriers and facilitators to GP-patient communication about emotional concerns in UK primary care: a systematic review.","volume":"37","author":"Parker","year":"2020","journal-title":"Fam Pract"},{"issue":"4","key":"irv260002r34","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1037\/1040-3590.11.4.466","article-title":"Self-monitoring with panic and anxiety disorders.","volume":"11","author":"Craske","year":"1999","journal-title":"Psychol Assess"},{"issue":"2","key":"irv260002r35","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.apnu.2017.11.015","article-title":"Effects of relaxation therapy on anxiety disorders: a systematic review and meta-analysis.","volume":"32","author":"Kim","year":"2018","journal-title":"Arch Psychiatr Nurs"},{"key":"irv260002r36","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.brat.2017.12.002","article-title":"Effects of mindfulness exercises as stand-alone intervention on symptoms of anxiety and depression: systematic review and meta-analysis.","volume":"102","author":"Blanck","year":"2018","journal-title":"Behav Res Ther"},{"issue":"2","key":"irv260002r37","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.beth.2009.01.007","article-title":"The science of cognitive therapy.","volume":"44","author":"Hofmann","year":"2013","journal-title":"Behav Ther"},{"key":"irv260002r38","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jad.2016.07.024","article-title":"Self-help strategies for sub-threshold anxiety: a Delphi consensus study to find messages suitable for population-wide promotion.","volume":"206","author":"Morgan","year":"2016","journal-title":"J Affect Disord"},{"key":"irv260002r39","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1741-7015-7-79","article-title":"Psychoeducation for depression, anxiety and psychological distress: a meta-analysis.","volume":"7","author":"Donker","year":"2009","journal-title":"BMC Med"},{"issue":"4","key":"irv260002r40","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.psc.2024.04.011","article-title":"Cognitive behavioral therapy for anxiety disorders.","volume":"47","author":"Trent","year":"2024","journal-title":"Psychiatr Clin North Am"},{"issue":"6","key":"irv260002r41","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/da.22728","article-title":"Cognitive behavioral therapy for anxiety and related disorders: a meta-analysis of randomized placebo-controlled trials.","volume":"35","author":"Carpenter","year":"2018","journal-title":"Depress Anxiety"},{"issue":"6","key":"irv260002r42","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1192\/bjp.2018.49","article-title":"Enduring effects of psychological treatments for anxiety disorders: meta-analysis of follow-up studies.","volume":"212","author":"Bandelow","year":"2018","journal-title":"Br J Psychiatry"},{"issue":"3","key":"irv260002r43","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1001\/jamapsychiatry.2019.3986","article-title":"Long-term outcomes of cognitive behavioral therapy for anxiety-related disorders: a systematic review and meta-analysis.","volume":"77","author":"van Dis","year":"2020","journal-title":"JAMA Psychiatry"},{"key":"irv260002r44","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.janxdis.2017.12.004","article-title":"Psychological interventions for anxiety in adult primary care patients: a review and recommendations for future research.","volume":"54","author":"Shepardson","year":"2018","journal-title":"J Anxiety Disord"},{"issue":"1","key":"irv260002r45","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1741-7015-8-38","article-title":"Brief psychological therapies for anxiety and depression in primary care: meta-analysis and meta-regression.","volume":"8","author":"Cape","year":"2010","journal-title":"BMC Med"},{"issue":"2","key":"irv260002r46","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1017\/S0033291712000670","article-title":"Psychological treatment of anxiety in primary care: a meta-analysis.","volume":"43","author":"Seekles","year":"2013","journal-title":"Psychol Med"},{"issue":"1","key":"irv260002r47","doi-asserted-by":"publisher","first-page":"20385","DOI":"10.1038\/s41598-021-99882-w","article-title":"A systematic review and meta-analysis of acceptance- and mindfulness-based interventions for DSM-5 anxiety disorders.","volume":"11","author":"Haller","year":"2021","journal-title":"Sci Rep"},{"issue":"4","key":"irv260002r48","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.psc.2017.08.008","article-title":"Mindfulness-based interventions for anxiety and depression.","volume":"40","author":"Hofmann","year":"2017","journal-title":"Psychiatr Clin North Am"},{"issue":"2","key":"irv260002r49","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1017\/S0033291721001999","article-title":"Two decades of digital interventions for anxiety disorders: a systematic review and meta-analysis of treatment effectiveness.","volume":"53","author":"Pauley","year":"2023","journal-title":"Psychol Med"},{"issue":"5","key":"irv260002r50","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.cpr.2012.04.002","article-title":"Self-help treatment of anxiety disorders: a meta-analysis and meta-regression of effects and potential moderators.","volume":"32","author":"Haug","year":"2012","journal-title":"Clin Psychol Rev"},{"issue":"1","key":"irv260002r51","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/wps.21183","article-title":"Current evidence on the efficacy of mental health smartphone apps for symptoms of depression and anxiety: a meta-analysis of 176 randomized controlled trials.","volume":"23","author":"Linardon","year":"2024","journal-title":"World Psychiatry"},{"issue":"2","key":"irv260002r52","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s10880-017-9531-x","article-title":"The Primary Care Behavioral Health (PCBH) model: an overview and operational definition.","volume":"25","author":"Reiter","year":"2018","journal-title":"J Clin Psychol Med Settings"},{"key":"irv260002r53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.genhosppsych.2018.04.002","article-title":"Patient outcomes associated with primary care behavioral health services: a systematic review.","volume":"53","author":"Possemato","year":"2018","journal-title":"Gen Hosp Psychiatry"},{"issue":"7","key":"irv260002r54","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/jpepsy\/jsae038","article-title":"A systematic review and meta-analysis of pediatric integrated primary care for the prevention and treatment of physical and behavioral health conditions.","volume":"50","author":"Hostutler","year":"2025","journal-title":"J Pediatr Psychol"},{"issue":"3","key":"irv260002r55","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/jclp.20539","article-title":"Impact of behavioral health consultant interventions on patient symptoms and functioning in an integrated family medicine clinic.","volume":"65","author":"Bryan","year":"2009","journal-title":"J Clin Psychol"},{"key":"irv260002r56","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12875-016-0466-3","article-title":"Collaborative care for anxiety disorders in primary care: a systematic review and meta-analysis.","volume":"17","author":"Muntingh","year":"2016","journal-title":"BMC Fam Pract"},{"issue":"10173","key":"irv260002r57","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/S0140-6736(18)31793-8","article-title":"Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis.","volume":"393","author":"Slee","year":"2019","journal-title":"Lancet"},{"key":"irv260002r58","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.580858","article-title":"Comparative remission rates and tolerability of drugs for Generalised Anxiety Disorder: a systematic review and network meta-analysis of double-blind randomized controlled trials.","volume":"11","author":"Kong","year":"2020","journal-title":"Front Pharmacol"},{"issue":"3","key":"irv260002r59","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/da.22854","article-title":"Systematic review and meta-analysis: dose-response curve of SSRIs and SNRIs in anxiety disorders.","volume":"36","author":"Jakubovski","year":"2019","journal-title":"Depress Anxiety"},{"issue":"6","key":"irv260002r60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003664","article-title":"Selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for anxiety, obsessive-compulsive, and stress disorders: a 3-level network meta-analysis.","volume":"18","author":"Gosmann","year":"2021","journal-title":"PLoS Med"},{"issue":"2","key":"irv260002r62","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1080\/15622975.2022.2086295","article-title":"World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders\u2014version 3. part I: anxiety disorders.","volume":"24","author":"Bandelow","year":"2023","journal-title":"World J Biol Psychiatry"},{"key":"irv260002r63","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1186\/1471-244X-14-S1-S1","article-title":"Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders.","volume":"14","author":"Katzman","year":"2014","journal-title":"BMC Psychiatry"},{"issue":"5","key":"irv260002r64","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1177\/0269881114525674","article-title":"Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology.","volume":"28","author":"Baldwin","year":"2014","journal-title":"J Psychopharmacol"},{"issue":"9","key":"irv260002r65","doi-asserted-by":"publisher","first-page":"3783","DOI":"10.1017\/S0033291723001630","article-title":"Incidence of adverse events and comparative tolerability of selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for the treatment of anxiety, obsessive-compulsive, and stress disorders: a systematic review and network meta-analysis.","volume":"53","author":"Gosmann","year":"2023","journal-title":"Psychol Med"},{"issue":"4","key":"irv260002r66","doi-asserted-by":"publisher","first-page":"409","DOI":"10.31887\/DCNS.2008.10.4\/kkelly","article-title":"Toward achieving optimal response: understanding and managing antidepressant side effects.","volume":"10","author":"Kelly","year":"2008","journal-title":"Dialogues Clin Neurosci"},{"issue":"4","key":"irv260002r67","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/hup.1019","article-title":"How long should a trial of escitalopram treatment be in patients with major depressive disorder, generalised anxiety disorder or social anxiety disorder? an exploration of the randomised controlled trial database.","volume":"24","author":"Baldwin","year":"2009","journal-title":"Hum Psychopharmacol"},{"key":"irv260002r68","doi-asserted-by":"publisher","first-page":"j3927","DOI":"10.1136\/bmj.j3927","article-title":"Risk of relapse after antidepressant discontinuation in anxiety disorders, obsessive-compulsive disorder, and post-traumatic stress disorder: systematic review and meta-analysis of relapse prevention trials.","volume":"358","author":"Batelaan","year":"2017","journal-title":"BMJ"},{"issue":"7","key":"irv260002r69","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1111\/jgs.18372","article-title":"American Geriatrics Society 2023 updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults.","volume":"71","author":"2023 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel","year":"2023","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"irv260002r70","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1097\/YIC.0000000000000078","article-title":"Efficacy of treatments for anxiety disorders: a meta-analysis.","volume":"30","author":"Bandelow","year":"2015","journal-title":"Int Clin Psychopharmacol"},{"issue":"1","key":"irv260002r71","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/YIC.0000000000000147","article-title":"Pregabalin for generalized anxiety disorder: an updated systematic review and meta-analysis.","volume":"32","author":"Generoso","year":"2017","journal-title":"Int Clin Psychopharmacol"},{"issue":"2","key":"irv260002r72","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1177\/0269881115612236","article-title":"Propranolol for the treatment of anxiety disorders: systematic review and meta-analysis.","volume":"30","author":"Steenen","year":"2016","journal-title":"J Psychopharmacol"},{"issue":"3","key":"irv260002r74","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1080\/15622970601110273","article-title":"Meta-analysis of randomized controlled comparisons of psychopharmacological and psychological treatments for anxiety disorders.","volume":"8","author":"Bandelow","year":"2007","journal-title":"World J Biol Psychiatry"},{"issue":"1","key":"irv260002r75","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/wps.20089","article-title":"Adding psychotherapy to antidepressant medication in depression and anxiety disorders: a meta-analysis.","volume":"13","author":"Cuijpers","year":"2014","journal-title":"World Psychiatry"},{"issue":"2","key":"irv260002r76","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1521\/ijct.2009.2.2.160","article-title":"Is it beneficial to add pharmacotherapy to cognitive-behavioral therapy when treating anxiety disorders? a meta-analytic review.","volume":"2","author":"Hofmann","year":"2009","journal-title":"Int J Cogn Ther"},{"issue":"4","key":"irv260002r77","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.psc.2017.08.007","article-title":"Can cognitive behavioral therapy for anxiety and depression be improved with pharmacotherapy? a meta-analysis.","volume":"40","author":"Tolin","year":"2017","journal-title":"Psychiatr Clin North Am"},{"issue":"9","key":"irv260002r78","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1002\/da.20676","article-title":"Characteristics and predictors of social phobia course in a longitudinal study of primary-care patients.","volume":"27","author":"Beard","year":"2010","journal-title":"Depress Anxiety"},{"issue":"2","key":"irv260002r79","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/01.nmd.0000198140.02154.32","article-title":"Characteristics and predictors of full and partial recovery from generalized anxiety disorder in primary care patients.","volume":"194","author":"Rodriguez","year":"2006","journal-title":"J Nerv Ment Dis"},{"issue":"19","key":"irv260002r80","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1001\/jama.2010.608","article-title":"Delivery of evidence-based treatment for multiple anxiety disorders in primary care: a randomized controlled trial.","volume":"303","author":"Roy-Byrne","year":"2010","journal-title":"JAMA"},{"key":"irv260002r81","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jpsychires.2016.08.015","article-title":"The use of waitlists as control conditions in anxiety disorders research.","volume":"83","author":"Patterson","year":"2016","journal-title":"J Psychiatr Res"},{"key":"irv260002r22","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425787","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2022","edition":"5th ed, Text Re"},{"key":"irv260002r30","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/978-1-59745-263-2_13","volume-title":"Anxiety Disorders: A Pocket Guide for Primary Care","author":"Helsley","year":"2008"},{"key":"irv260002r31","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/978-3-031-14372-4_3","volume-title":"The Medical Evaluation of Psychiatric Symptoms","author":"Jayanti","year":"2023"},{"key":"irv260002r61","volume-title":"Generalised Anxiety Disorder and Panic Disorder in Adults: Management","author":"National Institute for Health and Care Excellence","year":"2019"},{"key":"irv260002r73","unstructured":"Practice guideline for the treatment of patients with panic disorder: second edition. American Psychiatric Association. January 2009. Accessed July 22, 2025. https:\/\/psychiatryonline.org\/pb\/assets\/raw\/sitewide\/practice_guidelines\/guidelines\/panicdisorder.pdf"}],"container-title":["JAMA Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/articlepdf\/2848049\/jamainternal_shepardson_2026_rv_260002_1781812050.09333.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T15:00:42Z","timestamp":1783350042000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/fullarticle\/2848049"}},"subtitle":["A Review"],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":81,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamainternmed.2026.0395","relation":{},"ISSN":["2168-6106"],"issn-type":[{"value":"2168-6106","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,1]]}}}